Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 5 (5 total).

Reyes C, Van de Putte L, Falcón AP, Levy RA. 2004. Genes, culture, and medicines: Bridging gaps in treatment for Hispanic Americans. Washington, DC: National Alliance for Hispanic Health, 32 pp.

Annotation: This report brings together a growing body of scientific research demonstrating substantial disparities in pharmaceutical therapy for Hispanic Americans. The report discusses disparities in relation to asthma and Hispanic children, mental illness, and status of research; genetics and individualized response to drugs in Hispanics in relation to asthma, diabetes, heart attack, and Alzheimers disease; clinical implications of variations in genes regulating drug metabolism; undertreatment of coexisting conditions; and communication, culture, and implications of optimal pharmaceutical care. Statistical information is presented in figures throughout the report. The report includes conclusions, recommendations, and references.

Contact: National Alliance for Hispanic Health, 1501 16th Street, N.W., Washington, DC 20036-1401, Telephone: (202) 387-5000 Secondary Telephone: (866) 783-2645 Fax: E-mail: Web Site: http://www.hispanichealth.org Available from the website.

Keywords: Alzheimers disease, Asthma, Children, Communication, Cultural factors, Culture, Diabetes, Drug therapy, Genetics, Heart diseases, Hispanic Americans, Mental disorders, Pharmaceuticals, Research, Treatment

2001. MediLexicon. East Sussex, United Kingdom: MediLexicon International,

Annotation: This electronic resource provides a database of pharmaceutical and medical abbreviations and acronyms, plus a database of pharmaceutical companies, medical associations, hospitals, drugs, equipment, ICD9 codes. Links to a variety of medical and health resources are also provided.

Link

Keywords: Clinical coding, Acronyms, Dictionaries, Drugs, Electronic publications, Medical reference books, Online databases, Pharmaceuticals

National Governors' Association, Health Policy Studies Division. 2000. States face increased expenditures for pharmaceuticals. Washington, DC: National Governors' Association, Health Policy Studies Division, 4 pp. (Issue brief)

Contact: National Governors Association, 444 North Capitol Street, Suite 267, Washington, DC 20001-1512, Telephone: (202) 624-5300 Secondary Telephone: Contact Phone: (202) 624-3644 E-mail: [email protected] Contact E-mail: [email protected] Web Site: http://www.nga.org Available at no charge; also available from the website.

Keywords: Managed care, Medicaid, Pharmaceutical fees, Pharmaceuticals, State programs

Dijkstra H, Poot E, Wilczek I, eds. 1998. Biomedical research and orphan medicinal products: A roundtable conference organized by European Platform for Patients' Organisations, Science, and Industry, Brussels, 23 September 1997. [Brussels, Belgium]: European Platform for Patient's Organizations, Science and Industry, 122 pp.

Annotation: This book provide the texts of the presentations at a conference on biomedical research and orphan medicinal products. Section one addresses rare diseases. Section two discusses related research and development. Section three discusses legislation regarding orphan medicinal products. Section four discusses the related ethical aspects. And section five provides the related discussion of the conference.

Contact: European Platform for Patients' Organizations, Science and Industry, Square de Meeus-Rue de L'Industrie, 4, 1000 Brussels, Belgium Telephone: +32 2 503 13 07 Fax: +32 2 503 31 08 E-mail: [email protected] Web Site: http://www.epposi.org/ Available in libraries. Document Number: ISBN 90 261 1412 5.

Keywords: Conferences, Ethics, Europe, Legislation, Orphan drugs, Pharmaceuticals, Rare diseases, Research

Charrette A. 1997. Medicaid managed care. [Washington, DC]: Health Policy Tracking Service, 33 pp.

Annotation: This issue brief discusses legislation on Medicaid managed care that has at least passed one house of state legislatures. The summaries provided are not meant to be comprehensive, but to highlight certain issues and to give an overview of the trends that are emerging so far this year in terms of Medicaid managed care. Summaries are provided regarding creating or expanding Medicaid managed care programs, Medicaid managed care, caution on managed care for the elderly and persons with disabilities, oversight of managed care organizations and setting criteria for health maintenance organizations, protections for Medicaid managed care recipients, ensuring quality of care, Medicaid managed care fraud, and pharmaceuticals. Summaries are provided for legislation in California, Colorado, Connecticut, Florida, Hawaii, Illinois, Indiana, Kansas, Louisiana, Maryland, Michigan, Minnesota, Mississippi, Nevada, New Jersey, New Mexico, New York, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia, and Washington. This information is current through September 25, 1997.

Keywords: California, Colorado, Connecticut, Disabilities, Disabilities, Florida, Fraud, Hawaii, Health maintenance organizations, Illinois, Indiana, Kansas, Louisiana, Managed care, Maryland, Medicaid managed care, Michigan, Minnesota, Mississippi, Nevada, New Jersey, New Mexico, New York, North Dakota, Oklahoma, Older adults, Oregon, Pennsylvania, Pharmaceuticals, Quality assurance, Rhode Island, Special health care needs, State legislation, Tennessee, Texas, Virginia, Washington